These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 1879096)

  • 21. Pharmacokinetics of newer drugs in patients with renal impairment (Part I).
    Fillastre JP; Singlas E
    Clin Pharmacokinet; 1991 Apr; 20(4):293-310. PubMed ID: 2036748
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dose adjustment guidelines for medications in patients with renal impairment: how consistent are drug information sources?
    Khanal A; Castelino RL; Peterson GM; Jose MD
    Intern Med J; 2014 Jan; 44(1):77-85. PubMed ID: 24112311
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetic optimisation in the treatment of Pneumocystis carinii pneumonia.
    Vöhringer HF; Arastéh K
    Clin Pharmacokinet; 1993 May; 24(5):388-412. PubMed ID: 8504623
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Drug administration in critically ill patients with acute renal failure.
    Kroh UF
    New Horiz; 1995 Nov; 3(4):748-59. PubMed ID: 8574606
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Drugs in the intensive care unit--need for dosage adjustment in organ failure].
    Kroh UF; Lennartz H
    Klin Wochenschr; 1991; 69 Suppl 26():24-31. PubMed ID: 1813726
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical pharmacokinetics of antibacterial drugs in the elderly. Implications for selection and dosage.
    Meyers BR; Wilkinson P
    Clin Pharmacokinet; 1989 Dec; 17(6):385-95. PubMed ID: 2689039
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacodynamic basis for altered drug action in the elderly.
    Roberts J; Tumer N
    Clin Geriatr Med; 1988 Feb; 4(1):127-49. PubMed ID: 3278786
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical pharmacokinetics of newer antibacterial agents in liver disease.
    Westphal JF; Brogard JM
    Clin Pharmacokinet; 1993 Jan; 24(1):46-58. PubMed ID: 8448972
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The effect of angiotensin-converting enzyme inhibitors on the progression of chronic renal failure].
    Bernadet-Monrozies P; Rostaing L; Kamar N; Durand D
    Presse Med; 2002 Nov; 31(36):1714-20. PubMed ID: 12467154
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical pharmacokinetics of calcium antagonists. An update.
    Kelly JG; O'Malley K
    Clin Pharmacokinet; 1992 Jun; 22(6):416-33. PubMed ID: 1587055
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Retrospective studies and prospects of therapy for hypertension].
    Maisch B; Brilla C; Kruse T; Noll B; Bethge C
    Herz; 1995 Dec; 20(6):370-89. PubMed ID: 8582697
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nephroprotection by antihypertensive agents.
    Schmieder RE
    J Cardiovasc Pharmacol; 1994; 24 Suppl 2():S55-64. PubMed ID: 7898095
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Disposition of cardiovascular drugs in the elderly.
    Greenblatt DJ
    Med Clin North Am; 1989 Mar; 73(2):487-94. PubMed ID: 2645485
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drug dosing in patients with renal insufficiency.
    Bakris GL; Talbert R
    Postgrad Med; 1993 Dec; 94(8):153-164. PubMed ID: 29206546
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of milrinone in critically ill children.
    Bishara T; Seto WT; Trope A; Parshuram CS
    Can J Hosp Pharm; 2010 Nov; 63(6):420-8. PubMed ID: 22479014
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Delapril/manidipine.
    McCormack PL; Keating GM
    Drugs; 2006; 66(7):961-9. PubMed ID: 16740017
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drug dosage in patients during continuous renal replacement therapy. Pharmacokinetic and therapeutic considerations.
    Reetze-Bonorden P; Böhler J; Keller E
    Clin Pharmacokinet; 1993 May; 24(5):362-79. PubMed ID: 8504621
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical pharmacokinetics of angiotensin converting enzyme (ACE) inhibitors in renal failure.
    Hoyer J; Schulte KL; Lenz T
    Clin Pharmacokinet; 1993 Mar; 24(3):230-54. PubMed ID: 8462229
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drug dosage in end-stage renal disease (ESRD) patients undergoing haemodialysis. A predictive study based on a microcomputer program.
    Mac-Kay MV; Sanchez Burson J; Martinez-Lanao J; Dominguez-Gil A
    Clin Pharmacokinet; 1993 Sep; 25(3):243-57. PubMed ID: 8222463
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.